semaglutide compound fda alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products FDA issues warning about some

Semaglutide is a pure GLP-1 receptor agonist: it mimics glucagon-like peptide-1, a hormone your gut releases after eating

Diabetes Care 45(1):134141 Koekkoek PS, Kappelle LJ, van den Berg E, Rutten GE, Biessels GJ (2015) Cognitive function in patients with diabetes mellitus: guidance for daily care

Healing takes time

(2023, NEJM) examined dose-response pharmacokinetics in a Phase 2 research context and reported 24.2% mean body-composition changes at 48 weeks along with notable liver-fat reductions

It pairs a top-of-class metabolic peptide with a much smaller peptide that targets the cellular layer of fat burning

The sublingual suspension (liquid) is made using both commercially available and bulk ingredients, and SubMagna HMW anhydrous base